TD Cowen Reiterates Buy on Abbott Laboratories, Maintains $135 Price Target

TD Cowen analyst Joshua Jennings has reiterated a Buy rating on Abbott Laboratories (NYSE: ABT) and has maintained a price target of $135 for the stock. This endorsement suggests confidence in the company's future performance.